Rockefeller Capital Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177K Buy
1,782
+1,583
+795% +$206K ﹤0.01% 2571
2025
Q4
$24.2K Sell
199
-2,043
-91% -$256K ﹤0.01% 3426
2025
Q3
$252K Buy
+2,242
New +$262K ﹤0.01% 2111
2024
Q4
Sell
-10,216
Closed -$1.6M 1727
2024
Q3
$1.6M Buy
+10,216
New +$1.57M ﹤0.01% 1075
2023
Q3
Sell
-8,533
Closed -$603K 1807
2023
Q2
$603K Buy
8,533
+4,764
+126% +$365K ﹤0.01% 1268
2023
Q1
$284K Buy
3,769
+3,531
+1,484% +$244K ﹤0.01% 1612
2022
Q4
$14K Sell
238
-69
-22% -$3.67K ﹤0.01% 2940
2022
Q3
$12K Sell
307
-202
-40% -$8.79K ﹤0.01% 3018
2022
Q2
$15K Sell
509
-76
-13% -$2.03K ﹤0.01% 2911
2022
Q1
$15K Sell
585
-139
-19% -$2.49K ﹤0.01% 2862
2021
Q4
$13K Buy
724
+291
+67% +$7.29K ﹤0.01% 2852
2021
Q3
$14K Hold
433
﹤0.01% 2743
2021
Q2
$14K Hold
433
﹤0.01% 2646
2021
Q1
$17K Buy
433
+131
+43% +$4.03K ﹤0.01% 2356
2020
Q4
$6K Buy
+302
New +$4.47K ﹤0.01% 2399

Other funds holding TMDX

Rockefeller Capital Management's TMDX Position: Q1 2026 in Review

Rockefeller Capital Management increased its Transmedics (TMDX) stake by 795% in Q1 2026, buying an estimated $206K and bringing the position to 1,782 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #2571.

Rockefeller Capital Management first reported a position in TMDX in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.6M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Rockefeller Capital Management held 1,782 shares of Transmedics worth $177K as of Q1 2026.
  • Rockefeller Capital Management bought 1,583 Transmedics shares in Q1 2026, an estimated $206K.
  • Transmedics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2571 holding.
  • Rockefeller Capital Management first reported a position in Transmedics in Q4 2020 and has held it in 15 quarters since.
  • Rockefeller Capital Management's Transmedics position peaked at $1.6M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.